Skip to content
← Back to this collection

PUBLICATIONS · 9779704

High-dose melphalan, etoposide, and carboplatin followed by autologous stem-cell rescue in pediatric high-risk recurrent Wilms' tumor: a French Society of Pediatric Oncology study.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
J Clin Oncol
Publication date
1998 Oct
First author
Pein F

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Pein F
      type
      Author
    2. name
      Michon J
      type
      Author
    3. name
      Valteau-Couanet D
      type
      Author
    4. name
      Quintana E
      type
      Author
    5. name
      Frappaz D
      type
      Author
    6. name
      Vannier JP
      type
      Author
    7. name
      Philip T
      type
      Author
    8. name
      Bergeron C
      type
      Author
    9. name
      Baranzelli MC
      type
      Author
    10. name
      Thyss A
      type
      Author
    11. name
      Stephan JL
      type
      Author
    12. name
      Boutard P
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      Pein F
      type
      Author
    2. name
      Michon J
      type
      Author
    3. name
      Valteau-Couanet D
      type
      Author
    4. name
      Quintana E
      type
      Author
    5. name
      Frappaz D
      type
      Author
    6. name
      Vannier JP
      type
      Author
    7. name
      Philip T
      type
      Author
    8. name
      Bergeron C
      type
      Author
    9. name
      Baranzelli MC
      type
      Author
    10. name
      Thyss A
      type
      Author
    11. name
      Stephan JL
      type
      Author
    12. name
      Boutard P
      type
      Author
    bibliography ids
    1. nci-bib-da8d60c67c7b8dd95d26d0e0
    book metadata
    content sha256
    a49551f7ccfaf167fc3d19d8b1786b43bc7584dcc50e72c9d746cd47e89e44d4
    document type
    citation
    dois
    1. 10.1200/JCO.1998.16.10.3295
    electronic publication date
    display
    Source null
    precision
    missing
    year
    Source null
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:9779704
    immutable id
    pubmed:9779704@a49551f7ccfaf167fc3d19d8b1786b43bc7584dcc50e72c9d746cd47e89e44d4
    journal
    abbreviation
    J Clin Oncol
    issn electronic
    Source null
    issn print
    0732-183X
    issue
    10
    name
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology
    nlm unique id
    8309333
    pages
    3295-301
    volume
    16
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      9779704
      provenance
      batch id
      7e001e36165c25a91a06
      provider
      NCBI PubMed ESummary
      record sha256
      7858766c91c02d15356f8cc1c7bf47c6d24446b761eaf3141c526d0a1f77e6f8
      response sha256
      3515b9c50c264ae766881ea5a6c5cb10e3af8e45341fd57a5bedfa1946d08222
      retrieved at
      2026-09-09T23:45:31.509029+00:00
      publication date
      display
      1998 Oct
      precision
      month
      year
      1998
      publication types
      1. Journal Article
      2. Research Support, Non-U.S. Gov't
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/9779704/
      title
      High-dose melphalan, etoposide, and carboplatin followed by autologous stem-cell rescue in pediatric high-risk recurrent Wilms' tumor: a French Society of Pediatric Oncology study.

      Preserved source evidence · Not medical advice